Envoy Medical

We are thrilled to announce that the first patient has been successfully implanted at Mayo Clinic with our first-of-its-kind fully implanted Acclaim® #cochlearimplant. CAUTION: The fully implanted Acclaim cochlear implant is an investigational device. Limited by United States law to investigational use. #hearinghealth #hearingloss #hearingoptions #audpeeps #audiology

Happy Thanksgiving from Envoy Medical! As we gather to celebrate this season of gratitude, we would like to extend our heartfelt thanks to our valued customers, providers, and suppliers. #EnvoyMedical #Thanksgiving #Gratitude

Our CEO, Brent Lucas, was a recent special guest on the Big Biz Show, hosted by Bob "Sully" Sullivan and Mike Costa. In this interview, Brent discusses hearing health and loss, including Envoy Medical's innovative approach to hearing solutions. Watch the full interview here: https://lnkd.in/gumHVkEk The information presented is for educational purposes and is not intended to constitute medical or business advice or replace the independent medical judgment of a trained and licensed physician with respect to any patient needs or circumstances. Each person’s situation is unique and risks, outcomes, experience and results may vary. Talk to your healthcare provider about what may be right for you. Please see complete product instructions for use, including all product indications, contraindications, precautions and warnings. #EnvoyMedical #BigBizShow #HearingHealth $COCH

We're #hiring a new Clinical Support Audiologist in White Bear Lake, Minnesota. Apply today or share this post with your network.

Envoy Medical is pleased to announce the publication of a peer-reviewed study in Otology & Neurotology highlighting the early experiences of our investigational Fully Implanted Acclaim® Cochlear Implant (Acclaim CI). The paper, titled, "Early Hearing Outcomes and Audiological Experiences with a Novel Fully Implanted Cochlear Implant," presents initial results from our first-in-human, early feasibility study. Caution: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use. Learn More: https://lnkd.in/e6TFe4M6 #EnvoyMedical #AcclaimCochlearImplant $COCH

Today, we honor the brave men and women who have served our nation. Thank you for your courage, dedication, and service. #EnvoyMedical #VeteransDay

We are proud to announce that Envoy Medical has received another European patent for our Modular Cochlear Implant System. The patent relates to a modular cochlear implant system configured to receive input signals from an implantable source and a wireless receiving device and output a stimulation signal based on the received input signals and a programmable mixing ratio representative of the relative contributions of the input signals to the stimulation signal. Press release: https://lnkd.in/ehKci-G9 #EnvoyMedical #EuropeanPatent $COCH

Our Chief Financial Officer, David R. Wells, took center stage yesterday at the Spartan Capital Investor Conference 2024 at The Pierre Hotel in New York City. The conference provided an excellent platform for engaging discussions, one-on-one meetings with potential investors, and networking opportunities with leaders from various sectors. We're proud to have been represented among the 30+ innovative companies showcased at this premier event. #EnvoyMedical #SpartanCapitalInvestorConference

We are thrilled to announce our participation as a bronze sponsor and exhibitor at the FCOM 2024 + The EXPO Experience. The event starts on Friday, November 8th, with the exhibit hall opening at 12:00 PM. Our CEO, Brent Lucas, will join a panel of industry experts on November 9th from 10:30 to 11:00 AM to discuss the critical topic of "Reimbursement Challenges for New Devices and Procedures." #EnvoyMedical #FCOM2024 FCOMnow

We are proud to announce that the U.S. Food and Drug Administration (FDA) has approved our Investigational Device Exemption (IDE) application for the pivotal study of our Acclaim® Fully Implanted Cochlear Implant. “Receiving FDA approval to initiate this pivotal study marks a significant milestone in our efforts to bring this breakthrough hearing device to more people with severe to profound hearing loss,” said Brent Lucas, CEO of Envoy Medical. The Acclaim® Fully Implanted Cochlear Implant is differentiated from existing cochlear implants and may offer new option for hearing loss patients. CAUTION The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use. Continue reading: https://lnkd.in/ekRG5XzJ #EnvoyMedical #FDAApproved #HearingHealth $COCH